The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2024

Filed:

Feb. 16, 2022
Applicant:

The United States of America, As Represented BY the Secretary, Dept. of Health and Human Services, Bethesda, MD (US);

Inventors:

Alan T. Remaley, Bethesda, MD (US);

Scott M. Gordon, Lexington, KY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/07 (2006.01); A61K 38/10 (2006.01); A61K 38/58 (2006.01); A61K 38/17 (2006.01); A61K 47/54 (2017.01); A61K 47/60 (2017.01); A61K 38/08 (2019.01);
U.S. Cl.
CPC ...
A61K 38/005 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/1767 (2013.01); A61K 38/58 (2013.01); A61K 47/545 (2017.08); A61K 47/60 (2017.08);
Abstract

Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as A1AT-peptide-enriched HDL particles, and their use in various therapeutic contexts.


Find Patent Forward Citations

Loading…